rs373041389
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_003072.5(SMARCA4):c.3894C>A(p.Asp1298Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
SMARCA4
NM_003072.5 missense
NM_003072.5 missense
Scores
4
10
5
Clinical Significance
Conservation
PhyloP100: -1.73
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SMARCA4. . Gene score misZ 6.8459 (greater than the threshold 3.09). Trascript score misZ 8.7957 (greater than threshold 3.09). GenCC has associacion of gene with uterine corpus sarcoma, Coffin-Siris syndrome 1, intellectual disability, autosomal dominant 16, rhabdoid tumor predisposition syndrome 2, familial rhabdoid tumor, hereditary nonpolyposis colon cancer, Coffin-Siris syndrome.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.3894C>A | p.Asp1298Glu | missense_variant | 28/36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.3894C>A | p.Asp1298Glu | missense_variant | 28/35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.3894C>A | p.Asp1298Glu | missense_variant | 28/36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.3894C>A | p.Asp1298Glu | missense_variant | 28/35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.3795C>A | p.Asp1265Glu | missense_variant | 27/35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.3795C>A | p.Asp1265Glu | missense_variant | 28/35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.3795C>A | p.Asp1265Glu | missense_variant | 27/34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.3795C>A | p.Asp1265Glu | missense_variant | 27/34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.3795C>A | p.Asp1265Glu | missense_variant | 28/35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.3306C>A | p.Asp1102Glu | missense_variant | 25/32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.2538C>A | p.Asp846Glu | missense_variant | 21/28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.2520C>A | p.Asp840Glu | missense_variant | 20/27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.2379C>A | p.Asp793Glu | missense_variant | 20/27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.2247C>A | p.Asp749Glu | missense_variant | 19/25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.51C>A | p.Asp17Glu | missense_variant | 2/8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 08, 2017 | The p.D1298E variant (also known as c.3894C>A), located in coding exon 27 of the SMARCA4 gene, results from a C to A substitution at nucleotide position 3894. The aspartic acid at codon 1298 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;.;T;.;.;.;.;.;.;.;D;.;.;.;.;.;T;T;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;D;.;.;.;.;D;.;.;.;D;.;D;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
L;.;.;.;.;.;.;.;.;.;L;.;.;.;.;.;.;.;.;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;.;.;.;.;.;.;.;.;.;D;.;D;.;D;.;.;.;.;.;.;.
REVEL
Uncertain
Sift
Uncertain
D;.;.;.;.;.;.;.;.;.;D;.;D;.;D;.;.;.;.;.;.;.
Sift4G
Uncertain
D;.;.;.;.;.;.;.;.;.;D;.;D;D;D;D;D;D;.;.;.;.
Polyphen
D;.;D;.;.;.;.;.;.;.;D;.;.;.;.;.;.;D;.;.;.;.
Vest4
MutPred
Loss of phosphorylation at T1301 (P = 0.217);.;Loss of phosphorylation at T1301 (P = 0.217);.;.;.;.;.;.;.;Loss of phosphorylation at T1301 (P = 0.217);.;.;.;.;.;.;Loss of phosphorylation at T1301 (P = 0.217);.;.;.;.;
MVP
MPC
2.6
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at